tirzepatide fda approval for weight loss is FDA-approved management, with clinical trials showing average weight of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Retatrutide vs Tirzepatide vs Semaglutide

Peptide therapy for weight loss supports metabolic function, fat breakdown, and muscle recovery alongside GLP-1 medications

Its role is limited to facilitating access to telehealth services but does not involve the diagnosis, prescription, and treatment management to independent clinicians

Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A, et al

Its effects on the gut are primarily functional rather than reparative, and there is no established clinical evidence that it heals specific gastrointestinal pathology

Skin symptoms Autoimmune skin conditions like psoriasis, dermatomyositis, and lupus rashes may respond to the systemic anti-inflammatory effects of weight loss and reduced metabolic inflammation